Acute cardiac care & resuscitation

Current spectrum and outcomes of infarct-related cardiogenic shock: insights from the CULPRIT-SHOCK registry and randomized controlled trial

Eur Heart J Acute Cardiovasc CarePublished Cohort study of the CULPRIT-SHOCK randomized controlled trial (RCT) and registry

Authors' conclusion

In specialized centres in Europe, short- and long-term mortality of patients with infarct-related CS treated with an invasive strategy is still high and mainly depends on the extent of CAD.

Study context

Population
Consecutive patients with acute MI complicated by cardiogenic shock screened for CULPRIT-SHOCK (RCT and accompanying registry)369 in registry
Participants
1,075 patients
Primary endpoint
Total mortality
Follow-up
30 days and 1 year
Methodological details83 specialized centres in Europe, 1-year follow-up
  • 83 specialized centres in Europe
  • 1-year follow-up

Primary result

As reported in the abstract

Total mortality at 30 days

47.6%

Total mortality at 1 year

52.9%

Further findings

1-year mortality by extent of coronary artery disease (CAD)

Left main (LM) coronary artery stenosis
63.5%
Three-vessel CAD
56.6%
Two-vessel CAD
49.8%
One-vessel CAD
38.6%

Mechanical complications

Mechanical complications
21/1008; 2.1%
1-year mortality with mechanical complications
66.7%

Thrombolysis in myocardial infarction (TIMI) 3 patency of infarct vessel after PCI

TIMI 3 patency after PCI
83.6%

Original publication

Current spectrum and outcomes of infarct-related cardiogenic shock: insights from the CULPRIT-SHOCK registry and randomized controlled trial. Eur Heart J Acute Cardiovasc Care. Published 13 February 2024. doi:10.1093/ehjacc/zuae020

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.